Sanofi SA

Type: Company
Name: Sanofi SA
Nationality: France
Web Address: http://en.sanofi.com/
First reported 6 hours ago - Updated 5 hours ago - 2 reports

Impax to Sell Authorized Generic Renvela - Analyst Blog

Impax Laboratories, Inc. (NASDAQ: IPXL) announced that it has started shipping the authorized generic version of Sanofi's (NYSE: SNY) Renvela (800 mg) under its settlement agreement with the latter. The drug is approved for the control of serum phosphorus ... [Published Benzinga.com - 5 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

Merck, Sanofi hope for sales expansion with two-dose Gardasil switch

Now that the European Commission has officially approved a two-dose Gardasil regimen for early teens, Merck ($MRK) and Sanofi ($SNY)--who market the HPV vaccine in Europe through joint venture Sanofi Pasteur MSD--will see the number of shots per patient ... [Published FierceVaccines - 12 hours ago]
First reported Apr 16 2014 - Updated 13 hours ago - 3 reports

Ex-Sanofi Executive Cupo Gets 16 Months for Insider Trading

(Updates with Lazorchak sentencing in third paragraph.)April 17 (Bloomberg) -- A former Sanofi executive who cooperated with prosecutors was sentenced to 16 months in prison by a judge who called him a leader of an insider-trading ring that made $1.4 ... [Published Washington Post - 13 hours ago]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Sanofi and Pitt join up to test wannabe dengue blockbuster

The road to approval has been a long and costly one for Sanofi's ($SNY) dengue fever candidate, which is on the verge of regulatory applications after 20 years in the lab and more than $1.4 billion spent on R&D. Now, with over $1 billion in yearly sales ... [Published FierceVaccines - 13 hours ago]
First reported 15 hours ago - Updated 15 hours ago - 1 reports

Sanofi UK’s 2014 Patient Group Bursary Scheme offers £50k

Global healthcare provider Sanofi UK is again offering £50,000 to be shared amongst three organisations in its annual Patient Group Bursary Scheme. The company aims to support organisations that promote the needs and interests of patients.This year the ... [Published UK Fundraising - 15 hours ago]
First reported Apr 16 2014 - Updated 16 hours ago - 3 reports

Sanofi launches latest Patient Group Bursary Scheme

:56 in Pharmaceutical Company Product News Sanofi has announced the launch of its UK Patient Group Bursary Scheme, which has been expanded this year to provide more opportunities to smaller charities. Now entering its fourth consecutive year, the scheme ... [Published Zenopa - 16 hours ago]
First reported 19 hours ago - Updated 19 hours ago - 1 reports

‘Murky’ pharma payments in flu vax trial

A FLU vaccination trial has been hit with new controversy after training incentive payments from Sanofi for some participating pharmacists were described by the Pharmaceutical Society of Australia (PSA) as “a very murky area”.Sanofi, whose products Intanza ... [Published Medical Observer - 19 hours ago]
First reported 19 hours ago - Updated 19 hours ago - 1 reports

Sanofi files cases against Glenmark on patent infringement

Sanofi filed a patent infringement petition against Glenmark on their cardiac drug Multaq in the district court of Delaware. They filed the suit against Glenmark and Actavis wanting to prevent them from commercializing its ANDA productprior to the expiration ... [Published Terrapinn - 19 hours ago]
First reported Apr 16 2014 - Updated Apr 16 2014 - 3 reports

Sanofi launches Probi Digestis in Korea

Swedish biotechnology company Probi has announced the signing of a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare division of Sanofi Korea is making a major ... ... [Published Big News Network - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

Former Sanofi exec sentenced to 16 months in prison for insider trading

Morris Plains resident Mark Cupo, 53, was sentenced today in federal court in Newark, where he pleaded guilty on Oct. 7 after secretly recording the two primary traders in the ring for authorities.On April 9, one trader, Lawrence Grum, 50, of Livingston,was ... [Published Star Ledger - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 2 reports

Sanofi beefs up social media channels with Spanish Twitter push

Sanofi ($SNY) is stepping up its social media game with a new project in Spain. The French drugmaker has added a new Twitter handle to its Iberian lineup, @Sanofifarmacia, designed to create a pool of reference information and help community pharmacies ... [Published FiercePharma - Apr 16 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 2 reports

Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?

By Pharma Intelligence :Lyxumia (lixisenatide) for the treatment of type 2 diabetes is once-daily GLP-1 from Sanofi's ( SNY ) stable. It is a potential head to head competitor to Novo Nordisk's ( NVO ) Victoza ($2.1b - 2013 annual sales ). Currently consensus ... [Published BioPortfolio - Apr 16 2014]

Quotes

having any eye surgery. The newly issued educational statement states, "Patients with symptomatic cataracts may wish to consider cataract surgery prior to initiating non-emergent α1-antagonist therapy. Because tamsulosin is associated with the highest risk of IFIS, patients with cataracts may wish to consider a non-selective α1-antagonist as initial treatment." We have
...Vosoughi. "Although it has been reported more commonly with Rebif, it's not something limited to that manufacturer."
...Former head of Pfizer's R&D division John LaMattina told FirstWord "this is a well-designed initiative to bring together the creative forces of industry and government that could prove to be key in coming up with better treatments for this dreaded disease. Hopefully, this will inspire other such efforts."
The new approval could change some of that. The U K "s Joint Committee on Vaccination and Immunisation, for one, has already recommended that the country's National Health Service switch to the new plan, telling GP it could make the Gardasil program more cost-effective. And last month, Dr. George Kassianos, the Royal College of General Practitioners" head of vaccinations, told the publication the money saved would strengthen the case for extending the country's Gardasil program--currently only for...

More Content

All (2063) | News (1709) | Reports (0) | Blogs (229) | Audio/Video (0) | Fact Sheets (32) | Press Releases (87)
sort by: Date | Relevance
Impax to Sell Authorized Generic Renvela - Anal... [Published Benzinga.com - 5 hours ago]
How Are Orphan Drugmakers Faring in the Great B... [Published Motley Fool - 5 hours ago]
Impax to Sell Authorized Generic Renvela [Published Zacks.com - 6 hours ago]
New studies on IFIS prompt ASCRS/AAO educationa... [Published Eye World - 7 hours ago]
Serious Side Effect Seen in MS Patients on Inte... [Published General Medicine eJournal - 7 hours ago]
Southern Arizona following Flinn roadmap to bio... [Published Inside Tucson Business - 7 hours ago]
IMMUNOGEN : Announces Conference Call to Discus... [Published 4 Traders - 8 hours ago]
Study compares long-term effectiveness of diabe... [Published WUSTL Medicine & Healthcare News - 8 hours ago]
Tick invasion: Lyme spreading nationally — and ... [Published Waynepost - 8 hours ago]
Friday Five – 5 questions raised this week in p... [Published FirstWord Pharma - 9 hours ago]
New Report Available: Companion Diagnostics Par... [Published SBWire - 9 hours ago]
Clinical Stage Partnering Terms and Agreements ... [Published SBWire - 9 hours ago]
Tick invasion: Lyme spreading nationally and f... [Published Victor Post - 10 hours ago]
Biggest Movers in Healthcare Stocks Now – ALXN ... [Published InvestorPlace.com - 11 hours ago]
The ABCs of GMOs: Cornell professor fields ques... [Published Waynepost - 11 hours ago]
Asia On The Move: CFDA Names New Testing Agency... [Published Health News Daily - 12 hours ago]
Merck, Sanofi hope for sales expansion with two... [Published FierceVaccines - 12 hours ago]
Gardasil dose reduction could boost EU sales fo... [Published FiercePharma - 12 hours ago]
Gardasil® approved in the European Union for a ... [Published FierceVaccines - 12 hours ago]
Ex-Sanofi Executive Cupo Gets 16 Months for Ins... [Published Washington Post - 13 hours ago]
Sanofi and Pitt join up to test wannabe dengue ... [Published FierceVaccines - 13 hours ago]
Two Former Pharmaceutical/Medical Technology Ex... [Published United States Department of Justice - 14 hours ago]
Arch Biopartners Appoints Claude Allary to Boar... [Published MarketWired - 14 hours ago]
Earnings Primer: What's on Deck for Amgen Inc. ... [Published Motley Fool - 14 hours ago]
Tuberculosis: treatment and prevention [Published PMLive - 15 hours ago]
Oxford BioMedica Ocular Programs Leading The Way [Published Investing.com - 15 hours ago]
Sanofi UK’s 2014 Patient Group Bursary Scheme o... [Published UK Fundraising - 15 hours ago]
Cybersecurity, BofA, MF Global, Bridgestone: Co... [Published GARP - 15 hours ago]
Sanofi Diabetes launches easy-to-use insulin pe... [Published Pharma Field - 16 hours ago]
Marketing Awards 2014: OOH and Digital shortlists [Published Marketing Magazine Canada - 16 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Study compares long-term effectiveness of diabe... [Published WUSTL Medicine & Healthcare News - 8 hours ago]
Robert Boston In a five-year study, researchers are comparing long-term benefits and risks of four widely used diabetes drugs that will be given in combination with metformin (Gulcophage®), the most commonly prescribed medication for treating type 2 ...
Re: [tt] Douglas Belkin, Caroline Porter: Corpo... [Published TranshumanTech - Apr 16 2014]
On 04/13/2014 03:41 PM, © Robbins wrote:> Actually these "trends" have been recognized as in existence for> far longer . Relative to my own experience on the academy ( in> California, ) their both overt and covert "influence" relative to> ...
The Future of Clinical Data Sharing is Taking S... [Published eClinical Trends - Apr 16 2014]
Amazing!!  For profit, companies are recognizing that it’s in their interest to share data. It only takes some careful planning to protect their assets.  The extremely high cost of drug R&D has now made it clear that collaboration is necessary to ...
Sanofi launches Probi Digestis in Korea [Published PBR - News - Apr 16 2014]
Swedish biotechnology company Probi has announced the signing of a distribution and supply agreement with Sanofi. ...
Basketball Hall of Famer Nancy Lieberman Teams ... [Published PR Newswire: Financial Services - Apr 15 2014]
CHATTANOOGA, Tenn., April 15, 2014 /PRNewswire/ -- Nancy Lieberman, basketball hall of famer, coach and mom, has teamed up with Sanofi's consumer healthcare division Chattem Inc. to introduce a new, more effective player on the over-the-counter (OTC) ...
1 2 3 4 5 6 7 8 9 10 ...

Press Releases

sort by: Date | Relevance
Sanofi launches Probi Digestis® in Korea [Published GlobeNewswire: Advertising News - Apr 15 2014]
Health Care Sector Stocks under Review -- Resea... [Published Financial Services - Apr 08 2014]
Sanofi: Genzyme to Resubmit Lemtrada Applicatio... [Published GlobeNewswire: Acquisitions News - Apr 07 2014]
Genzyme to Resubmit LemtradaTM Application for ... [Published Genzyme Press Release - Apr 07 2014]
Sanofi Appoints Dr. Anne C. Beal to the Newly C... [Published GlobeNewswire: Advertising News - Mar 31 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.